RecruitingNCT06554145
Development and Evaluation of AI Program for Predicting Bacterial Species From Urine Gram Stain Specimens
Sponsor
GramEye
Enrollment
15,000 participants
Start Date
Sep 25, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this research is to develop an AI that estimates bacterial species from Gram staining images of urine specimens, and to evaluate the accuracy and labor reduction effect of Gram staining Automation system equipped with this AI.
Eligibility
Inclusion Criteria1
- Specimens for which urine culture and urine Gram staining tests were performed for clinical purposes
Exclusion Criteria1
- Samples for which suspension of use has been requested
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06554145
Related Trials
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
NCT0564510761 locations
Retrospective Observational Study on Infective Complications and Outcome of Patients With ALL Treated With INO
NCT060256821 location
Study of the Involvement of IL-17 / IL-22 Pathway in Bacterial Exacerbations of COPD
NCT026553024 locations